1:00 PM - 2:00 PM
Senior Product Manager Interview
Sarah Jenkins
Location
hybrid, Menlo Park, California, United States
Salary
$128k – $149k/yr
Commitment
Full Time
Level
Junior (<2 years)
Join a team of brilliant, passionate innovators determined to transform healthcare. At BillionToOne, we've built a category-defining, publicly traded company on Nasdaq where transparency fuels trust, collaboration drives breakthroughs, and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all. We don't just aim for incremental improvements; we build products that are 10x better than anything that exists today.
Our scientists, engineers, sales executives, and visionaries are united by an unwavering commitment to changing the standard of care in prenatal and cancer diagnostics. This is where cutting-edge science meets human compassion, and every innovation you contribute helps remove the fear of the unknown from some of life's most critical medical moments.
If you're driven by purpose, energized by innovation, and ready to help shape the future of precision medicine at scale, this is where you belong.
Must possess an active and valid CLS or Clinical Genetic Molecular Biologist Scientist (CGMBS) license issued by the state of California pursuant to Division 2, Chapter 3 of the California Business and Professions Code or to practice medicine, osteopathy or podiatry pursuant to Division 2, Chapter 5 of the California Business and Professions Code appropriate to the specialty they are performing.
Bachelor's degree or higher in Biomedical Laboratory Sciences, Clinical Laboratory Science, Molecular Biology, Genetics, or a related scientific discipline, consistent with applicable licensure requirements.
At least one year of clinical laboratory experience or equivalent experience in a high-complexity, high-volume molecular diagnostic clinical laboratory environment.
Working alongside brilliant, kind, passionate and dedicated colleagues, in an empowering environment, toward a global vision, striving for a future in which transformative molecular diagnostics can help millions of patients.